Invasive adenocarcinoma with bronchoalveolar features: A population-based evaluation of the extent of resection in bronchoalveolar cell carcinoma Bryan.

Slides:

Advertisements

Similar presentations

Manuel J. Antunes, MD, PhD, DSc

Advertisements

Influence of diabetes on survival in patients with cystic fibrosis before and after lung transplantation Don Hayes, MD, MS, Alpa V. Patel, MD, Sylvester.

Stephen R. Broderick, MD, MPHS

True Negative Predictive Value of Endobronchial Ultrasound in Lung Cancer: Are We Being Conservative Enough? Bryan A. Whitson, MD, PhD, Shawn S. Groth,

Michael Y. Chang, MD, MPH, Steven J. Mentzer, MD, Yolonda L

Effect of tumor size on prognosis in patients with non–small cell lung cancer: The role of segmentectomy as a type of lesser resection Morihito Okada,

Surgical–pathologic factors affect long-term outcomes in stage IB (pT2 N0 M0) non– small cell lung cancer: A heterogeneous disease Chung-Ping Hsu, MD,

Survival of patients with distal esophageal and gastric cardia tumors: A population- based analysis of gastroesophageal junction carcinomas Bryan A. Whitson,

Pulmonary resection for metastases from hepatocellular carcinoma: Factors influencing prognosis Takahito Nakagawa, MD, Toshiya Kamiyama, MD, Kazuaki.

Paul J. Scheel, BS, Traves D. Crabtree, MD, Jennifer M

Impact of tumor size on outcomes after anatomic lung resection for stage 1A non–small cell lung cancer based on the current staging system Shamus R.

Yih-Leong Chang, MD, Chen-Tu Wu, MD, Yung-Chie Lee, MD, PhD

Esophageal submucosa: The watershed for esophageal cancer

Radical sublobar resection for small-sized non–small cell lung cancer: A multicenter study Morihito Okada, MD, PhD, Teruaki Koike, MD, PhD, Masahiko.

Outcomes of unexpected pathologic N1 and N2 disease after video-assisted thoracic surgery lobectomy for clinical stage I non–small cell lung cancer Hong.

Intrinsic cardiac stem cells are essential for regeneration

Influence of diabetes on survival in patients with cystic fibrosis before and after lung transplantation Don Hayes, MD, MS, Alpa V. Patel, MD, Sylvester.

Centers for Disease Control “increased-risk” organ donor: Not so risky? Francis D. Pagani, MD, PhD The Journal of Thoracic and Cardiovascular Surgery

John M. Varlotto, MD, Abram Recht, MD, John C. Flickinger, MD, Laura N

William M. DeCampli, MD, PhD

Patterns of survival and recurrence after surgical treatment of early stage non–small cell lung carcinoma in the ACOSOG Z0030 (ALLIANCE) trial Stacey.

Go on-pump or off-pump in diabetic patients?

Conditional Cancer-Specific Versus Cardiovascular-Specific Survival After Lobectomy for Stage I Non-Small Cell Lung Cancer Shawn S. Groth, MD, MS, Natasha.

Pharyngostomy tubes for gastric conduit decompression

Shawn S. Groth, MD, Bryan M. Burt, MD

The lord of the rings Antonio Miceli, MD, PhD

Survival After Lobectomy Versus Segmentectomy for Stage I Non-Small Cell Lung Cancer: A Population-Based Analysis Bryan A. Whitson, MD, PhD, Shawn S.

Esophagectomy versus endoscopic resection for patients with early-stage adenocarcinoma: Mercedes versus Tesla Toni Lerut, MD The Journal of Thoracic.

A systematic review and meta-analysis of stereotactic body radiation therapy versus surgery for patients with non–small cell lung cancer Christopher.

Impact of positive pleural lavage cytology on survival in patients having lung resection for non–small-cell lung cancer: An international individual patient.

It's not “just a shunt” but sometimes it should be…

Do we need a bibliometrician to know which way the wind is blowing?

Endobronchial Ultrasound-Guided Fine-Needle Aspiration of Mediastinal Lymph Nodes: A Single Institution's Early Learning Curve Shawn S. Groth, MD, Bryan.

A first start for lung transplantation?

Required area of lymph node sampling during segmentectomy for clinical stage IA non– small cell lung cancer Hiroaki Nomori, MD, PhD, Yasuomi Ohba, MD,

Stephen R. Broderick, MD, MPHS

Shawn S. Groth, MD, MS, R. Taylor Ripley, MD, Bryan M. Burt, MD

Determination of the minimum number of lymph nodes to examine to maximize survival in patients with esophageal carcinoma: Data from the Surveillance Epidemiology.

Joseph A. Dearani, MD, Michael J. Ackerman, MD, PhD

Yusuke Takahashi, MD, PhD, Prasad S. Adusumilli, MD

Chronic obstructive pulmonary disease severity influences outcomes after off-pump coronary artery bypass Benjamin Medalion, MD, Michael G. Katz, MD,

Resection of primary lung cancer with incidental pleural seeding: Seeds of change or reap what you sow? Jules Lin, MD The Journal of Thoracic and Cardiovascular.

Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD

Niv Ad, MD, Lawrence M. Wei, MD

Internal validation of risk models in lung resection surgery: Bootstrap versus training- and-test sampling Alessandro Brunelli, MD, Gaetano Rocco, MD

The Ross procedure: Time to reevaluate the guidelines

Manuel J. Antunes, MD, PhD, DSc

Video-assisted resection for lung cancer results in fewer complications Lunxu Liu, PhD, MD, FRCS The Journal of Thoracic and Cardiovascular Surgery

Pathologic complete response after esophagectomy following neoadjuvant chemoradiation therapy for esophageal carcinoma: A cure sometimes? Shawn S. Groth,

Passing the torch The Journal of Thoracic and Cardiovascular Surgery

Carcinoma of the esophagus: Prognostic significance of histologic type

Extent of lymphadenectomy is associated with oncological efficacy of sublobar resection for lung cancer ≤2 cm Brendon M. Stiles, MD, Jialin Mao, MD,

The ascent of POEM: Double-tunnel per oral endoscopic re-myotomy

The harder one looks, the more one finds

Bryan M. Burt, MD The Journal of Thoracic and Cardiovascular Surgery

Serratus Anterior Transposition Muscle Flaps for Bronchial Coverage: Technique and Functional Outcomes Shawn S. Groth, MD, Bryan A. Whitson, MD, PhD,

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

The future of cardiac surgery training: A survival guide

Therapeutic R2 resection for pleural mesothelioma

“The more things change…”: The challenges ahead

Kiran H. Lagisetty, David G. Beer, Andrew C. Chang

Carinal surgery: A single-institution experience spanning 2 decades

Energized lung resections

Of mice and men… The Journal of Thoracic and Cardiovascular Surgery

Who should decide margin length in pulmonary excision of lung cancer?

Surveillance Epidemiology and End Results Evaluation of the Role of Surgery for Stage I Small Cell Lung Cancer James B. Yu, MD, Roy H. Decker, MD, PhD,

Is there a benefit to continuing with resection of all sites of disease when clinically occult pleural metastases from non–small cell carcinoma are found?

Edward Y. Chan, MD, Michael J. Reardon, MD

Proceed with caution: The importance of surveillance in patients with pathologic complete response after chemoradiation therapy plus surgery for esophageal.

Presentation transcript:

Invasive adenocarcinoma with bronchoalveolar features: A population-based evaluation of the extent of resection in bronchoalveolar cell carcinoma Bryan A. Whitson, MD, PhD, Shawn S. Groth, MD, MS, Rafael S. Andrade, MD, Mohi O. Mitiek, MD, Michael A. Maddaus, MD, Jonathan D’Cunha, MD, PhD The Journal of Thoracic and Cardiovascular Surgery Volume 143, Issue 3, Pages 591-600.e1 (March 2012) DOI: 10.1016/j.jtcvs.2011.10.088 Copyright © 2012 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Sample inclusion and exclusion selection criteria. BAC, Bronchoalveolar cell carcinoma; SEER, Surveillance, Epidemiology, and End Results. The Journal of Thoracic and Cardiovascular Surgery 2012 143, 591-600.e1DOI: (10.1016/j.jtcvs.2011.10.088) Copyright © 2012 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 (A) Overall survival and (B) cancer-specific survival for patients with bronchoalveolar cell carcinoma histologic features who underwent either lobar or sublobar resection. (C) Overall survival and (D) cancer-specific survival for those patients who underwent anatomic resection (lobectomy or segmentectomy) and nonanatomic resection (wedge resection). Survival denoted on y-axis, with time in months along x-axis. Below the graph, number at risk for each is indicated. The Journal of Thoracic and Cardiovascular Surgery 2012 143, 591-600.e1DOI: (10.1016/j.jtcvs.2011.10.088) Copyright © 2012 The American Association for Thoracic Surgery Terms and Conditions